[ad_1]
WASHINGTON – Pharmaceutical company Pfizer said Tuesday in a statement that CEO Ian Read had agreed to "postpone the company's price increases that came into effect July 1 to give the president the right to". opportunity for health care system. " President Trump tweeted on Tuesday that Pfizer "is pushing back price increases, so American patients are not paying more."
million. Trump tweeted that he and health secretary Alex Azar discussed the issue on Tuesday with Read.
I just spoke with Pfizer's CEO and @SecAzar about our drug price plan. Pfizer is pushing back price increases, so American patients are not paying more. We congratulate Pfizer on this decision and hope that other companies will do the same. Good news for the American people!
– Donald J. Trump (@realDonaldTrump) July 10, 2018
Pfizer says he'll "bring those prices back to their levels before July 1 as soon as it's technically possible . "
Trump complained of price increases on Twitter on Monday, writing:" Pfizer and others should be ashamed of having raised the price of drugs for no reason, they are simply taking advantage of the poor and other people unable to defend themselves. "[19659003] Pfizer and others should be ashamed of having increased the price of drugs for no reason.They simply benefit the poor and other people unable to defend themselves , while offering at the same time unbeatable prices to other countries in Europe and elsewhere.We will respond!
– Donald J. Trump (@realDonaldTrump) 9 July 2018
Pfizer's shares briefly became negative on Monday after the tweet, but rose slightly late in the afternoon.
The Financial Times reported last week that Pfizer had raised prices of about 100 drugs, his two the 12th move of the year one month after Trump reported that drug companies would soon slash prices. The average wholesale price of a 100 mg Viagra pill increased from $ 73.85 in early 2018 to $ 88.45, while a bottle of Xalatan eye drops for glaucoma rose to 107 , $ 05 compared to $ 89.38 at the beginning of the year. according to the report.
